A Phase II Study of Stereotactic Body Radiotherapy (SBRT) for Low-Intermediate-High Risk Prostate Cancer Using Helical Tomotherapy: Dose-volumetric parameters predicting early toxicity

A Phase II Study of Stereotactic Body Radiotherapy (SBRT) for Low-Intermediate-High Risk Prostate Cancer Using Helical Tomotherapy: Dose-volumetric parameters predicting early toxicity

Endpoint: To assess early urinary (GU) and rectal (GI) toxicities after helical tomotherapy Stereotactic Body Radiation Therapy (SBRT), and to determine their predictive factors.Methods: Since May 2012 forty-five prostate cancer patients were treated with 8 fractions of 5.48 (low risk, 29%) or 5.65...

Full description

Bibliographic Details
Main Authors: Victor A Macias, Manuel eBlanco, Inmaculada eBarrera, Rafael eGarcia
Format: Article
Language:English
Published: Frontiers Media S.A. 2014-11-01
Series:Frontiers in Oncology
Subjects:
prostate cancer
stereotactic body radiation therapy
tomotherapy
ipss
Predictors Toxicity
Common Toxicity Criteria (CTC)
Online Access:http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00336/full

Similar Items

Similar Items